Medartis : Press release Medartis not to purse convertible bond placement
April 07, 2022
Share
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Medartis has decided not to pursue the convertible bond placement
The Board of Medartis has decided not to pursue the planned convertible bond placement, which was announced on Thursday evening. The bookbuilding exercise generated a substantial amount of demand, but did not fully meet the Company's expectations. The Company may return to the market when conditions improve.
Contact
Medartis Corporate Communications
Investor contact:investor.relations@medartis.com Media contact:corporate.communication@medartis.com +41 61 633 37 36
About Medartis
Founded in 1997 and headquartered in Basel, Switzerland, Medartis is one of the world's leading manufacturers and providers of medical devices for surgical fixation of bone fractures for upper and lower extremities as well as for the craniomaxillofacial region. Medartis employs approx. 700 individuals across its 14 locations, with products offered in over 50 countries globally. Medartis is committed to providing surgeons and operating theatre personnel with the most innovative titanium implants and instruments as well as best-in-class service. For more information, please visitwww.medartis.com.
Page 1 of 1
Attachments
Original Link
Original Document
Permalink
Disclaimer
Medartis Holding AG published this content on 08 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 April 2022 10:34:16 UTC.
Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.
MEDARTIS HOLDING AG 
